Physician
Mountain Area Health Education Center, INC.
Mountain Area Health Education Center, INC. was paid $14.23M by Medicaid between Jan 2018 and Dec 2024, across 82 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 57% of everything it billed.
33Billing provider infoMOUNTAIN AREA HEALTH EDUCATION CENTER, INC.
ASHEVILLE, NC 28803
ASHEVILLE, NC 28803
33aNPI1952356388assigned 05/24/2006
33bProvider typeChild & Adolescent Psychiatry Physician
28Total paid$14.23M
24GClaims513,459
24DCodes billed82
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Child & Adolescent Psychiatry Physician providers in North Carolina
Rank by total paid#2 of 20
Median peer was paid$184K
This provider vs. median77×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official HATHAWAY, WILLIAM controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25,016 | $714K | |
| 2019 | 26,804 | $910K | |
| 2020 | 24,920 | $887K | |
| 2021 | 54,303 | $1.40M | |
| 2022 | 135,845 | $2.48M | |
| 2023 | 118,743 | $3.87M | |
| 2024incomplete | 127,828 | $3.97M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 57% | 49,086 | 37,970 | $8.10M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 59,440 | 44,104 | $2.37M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 47,836 | 36,470 | $1.76M |
| 99199 | Unlisted special service, procedure or report | 9.3% | 279,270 | 135,228 | $1.32M |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.1% | 14,028 | 10,396 | $152K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 1,892 | 1,345 | $109K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,838 | 2,060 | $66K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 1,143 | 897 | $51K |
| 96127 | <1% | 15,741 | 10,435 | $49K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 2,559 | 2,012 | $41K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 560 | 409 | $37K |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 28 | 20 | $16K |
70 more codes
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 38 | $15K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 868 | $14K |
| 80305 | <1% | 3,679 | $14K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 105 | $13K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 278 | $13K |
| 90686 | <1% | 4,241 | $13K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 244 | $11K |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,822 | $11K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,649 | $8K |
| 0012A | <1% | 93 | $6K | |
| 0011A | <1% | 104 | $5K | |
| 99051 | <1% | 184 | $4K | |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 147 | $3K |
| 0002A | <1% | 59 | $3K | |
| 0031A | <1% | 41 | $2K | |
| 92551 | <1% | 2,724 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 260 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 306 | $2K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 249 | $2K |
| 96160 | <1% | 765 | $2K | |
| 96161 | <1% | 667 | $2K | |
| 99442 | <1% | 51 | $2K | |
| 0001A | <1% | 58 | $2K | |
| D1206 | Topical application of fluoride varnish | <1% | 146 | $1K |
| 59025 | Fetal non-stress test | <1% | 76 | $1K |
| 97802 | <1% | 35 | $1K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 14 | $1K |
| 87428 | <1% | 90 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 117 | $1K |
| 0071A | <1% | 23 | $1K | |
| 99460 | <1% | 15 | $1K | |
| 80061 | Lipid panel | <1% | 61 | $943.06 |
| 99173 | <1% | 3,203 | $890.27 | |
| 0240U | <1% | 20 | $855.78 | |
| 97803 | <1% | 34 | $572.67 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 27 | $537.20 |
| 83655 | <1% | 27 | $407.68 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 23 | $358.87 |
| 90734 | <1% | 23 | $357.04 | |
| 80053 | Comprehensive metabolic panel | <1% | 44 | $262.56 |
| 90670 | <1% | 425 | $184.68 | |
| 81025 | <1% | 33 | $160.29 | |
| 90715 | <1% | 22 | $160.04 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 19 | $156.33 |
| 85027 | <1% | 13 | $70.92 | |
| 81003 | <1% | 26 | $58.20 | |
| 85018 | <1% | 40 | $55.26 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 25 | $39.75 |
| 90633 | <1% | 35 | $32.14 | |
| 90656 | <1% | 43 | $21.79 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 25 | $1.60 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 117 | $0.00 |
| 2014F | 0% | 327 | $0.00 | |
| 91300 | 0% | 123 | $0.00 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 28 | $0.00 |
| 90685 | 0% | 13 | $0.00 | |
| 99000 | 0% | 5,068 | $0.00 | |
| 3008F | 0% | 3,392 | $0.00 | |
| 91301 | 0% | 215 | $0.00 | |
| 91307 | 0% | 20 | $0.00 | |
| 90698 | 0% | 52 | $0.00 | |
| 36416 | 0% | 47 | $0.00 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 0% | 47 | $0.00 |
| 99493 | 0% | 18 | $0.00 | |
| 4037F | 0% | 78 | $0.00 | |
| 84999 | 0% | 96 | $0.00 | |
| 90680 | 0% | 12 | $0.00 | |
| 90744 | 0% | 12 | $0.00 | |
| 99441 | 0% | 19 | $0.00 | |
| 91303 | 0% | 38 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHATHAWAY, WILLIAM (CEO)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.